Tepezza Hearing Loss Lawsuit
Did you or a loved one experience hearing loss or tinnitus after receiving Tepezza treatment
Compensation may be availableTepezza (teprotumumab), manufactured by Horizon Therapeutics, is the first and only FDA-approved prescription medication to treat Thyroid Eye Disease (TED). While initially marketed as an effective treatment for this debilitating condition in moderate-to-severe cases, recent studies have revealed that Tepezza is linked to a significantly higher risk of permanent hearing damages than what was disclosed during the FDA approval process.
Patients who have suffered hearing loss or tinnitus after receiving Tepezza infusions may be entitled to significant compensation.
Serious Hearing Complications from Tepezza
Tepezza works by blocking insulin-like growth factor-1 receptors (IGF-1R), which helps reduce the inflammation and tissue expansion behind the eyes caused by Thyroid Eye Disease. However, these same receptors play a critical role in maintaining auditory function.
Reported hearing complications after taking Tepezza may include:
- Permanent or partial hearing loss
- Sensorineural hearing loss (SNHL)
- Tinnitus (ringing in the ears)
- Ear plugging, fullness, or pressure
- Autophony (abnormally loud hearing of one’s own voice)
- Muffled hearing
- Decreased word comprehension
- Patulous Eustachian tube dysfunction
Even months after discontinuing Tepezza treatment, patients may still suffer from persistent, long-term hearing problems. In many cases, the hearing loss is severe enough that they require the use of hearing aids to manage their condition.
Do not stop taking a prescribed medication or stop using a prescribed medical device without first consulting with your doctor. Discontinuing a prescribed medication or use of a prescribed medical device without your doctor’s advice can result in injury or death. Notwithstanding claims relating to certain drugs and medical devices, the drug or medical device may remain approved by the U.S. FDA.
